Gallagher Cam
Insider CIK 1557832 · IRD Director · ZNTL President, Interim CFO, Director · SRNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRD Opus Genetics, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-08 | 784,314 | — | $0 | 0 | SEC↗ |
| IRD Opus Genetics, Inc. | M Exercise | 2026-09-08 | 2026-09-08 | 784,314 | $1.15 | $902.0K | 2,800,111 | SEC↗ |
| IRD Opus Genetics, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-08 | 784,314 | — | $0 | 0 | SEC↗ |
| IRD Opus Genetics, Inc. | M Exercise | 2026-09-08 | 2026-09-08 | 784,314 | $1.15 | $902.0K | 2,800,111 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2026-04-20 | 2026-04-22 | 24,367 | — | $0 | 2,015,797 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2026-01-06 | 2026-01-08 | 67,000 | — | $0 | 1,991,430 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-12-31 | 2025-12-31 | 33,000 | — | $0 | 1,924,430 | SEC↗ |
| IRD Opus Genetics, Inc. | P Buy | 2025-12-29 | 2025-12-31 | 83,000 | $1.97 | $163.5K | 83,000 | SEC↗ |
| IRD Opus Genetics, Inc. | P Buy | 2025-12-29 | 2025-12-31 | 81,000 | $1.98 | $160.4K | 1,891,430 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-08-25 | 2025-08-27 | 869,565 | $1.15 | $1000.0K | 1,810,430 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award deriv | 2025-04-30 | 2025-05-02 | 79,592 | — | $0 | 79,592 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-04-30 | 2025-05-02 | 79,504 | — | $0 | 940,865 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award deriv | 2025-03-24 | 2025-03-26 | 784,314 | — | $0 | 784,314 | SEC↗ |
| IRD Opus Genetics, Inc. | A Award | 2025-03-24 | 2025-03-26 | 784,314 | — | $0 | 861,361 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 35,181 | — | $0 | 35,181 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2024-06-11 | 2024-06-13 | 41,143 | — | $0 | 77,047 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-05-31 | 2024-05-31 | 9,597 | $11.98 | $115.0K | 633,680 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-02-12 | 2024-02-12 | 1,173 | $11.44 | $13.4K | 643,277 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-02-02 | 2024-02-05 | 11,552 | $11.54 | $133.3K | 644,450 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 192,500 | — | $0 | 192,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-02-01 | 2024-02-05 | 192,500 | — | $0 | 656,002 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 9,639 | — | $0 | 9,639 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2023-06-06 | 2023-06-08 | 10,976 | — | $0 | 35,904 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-05-31 | 2023-05-31 | 18,526 | $26.21 | $485.6K | 463,502 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-05-31 | 2023-05-31 | 9,242 | $26.40 | $244.0K | 482,028 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-14 | 2023-02-14 | 8,501 | $19.96 | $169.7K | 491,270 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-13 | 2023-02-14 | 3,332 | $20.42 | $68.0K | 499,771 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-06 | 2023-02-06 | 9,428 | $22.22 | $209.5K | 503,675 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-06 | 2023-02-06 | 572 | $23.04 | $13.2K | 503,103 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2023-02-01 | 2023-02-01 | 233,908 | — | $0 | 233,908 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2023-02-01 | 2023-02-01 | 161,092 | — | $0 | 513,103 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-01-17 | 2023-01-18 | 500 | $24.87 | $12.4K | 352,011 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-01-17 | 2023-01-18 | 9,500 | $24.11 | $229.0K | 352,511 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-01-05 | 2023-01-05 | 300 | $21.46 | $6.4K | 362,011 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-01-05 | 2023-01-05 | 9,700 | $21.01 | $203.8K | 362,311 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise deriv | 2023-01-04 | 2023-01-06 | 1,574 | — | $0 | 0 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | X Exercise | 2023-01-04 | 2023-01-06 | 1,574 | — | $0 | 24,928 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-11-15 | 2022-11-15 | 900 | $23.48 | $21.1K | 372,011 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-11-15 | 2022-11-15 | 11,600 | $22.72 | $263.6K | 372,911 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-11-08 | 2022-11-08 | 12,374 | $23.56 | $291.5K | 384,511 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-11-07 | 2022-11-08 | 157 | $24.24 | $3.8K | 396,885 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-11-07 | 2022-11-08 | 12,343 | $23.66 | $292.0K | 397,042 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-10-17 | 2022-10-17 | 12,500 | $23.51 | $293.9K | 409,385 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-10-06 | 2022-10-07 | 10,000 | $22.62 | $226.2K | 421,885 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-10-05 | 2022-10-07 | 5,496 | $22.83 | $125.5K | 431,885 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-10-05 | 2022-10-07 | 7,004 | $21.92 | $153.5K | 437,381 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-09-16 | 2022-09-16 | 8,866 | $24.38 | $216.2K | 445,519 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-09-16 | 2022-09-16 | 1,134 | $24.99 | $28.3K | 444,385 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-09-15 | 2022-09-16 | 4,074 | $25.59 | $104.3K | 454,385 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-09-15 | 2022-09-16 | 8,426 | $25.10 | $211.5K | 458,459 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-05-30 | 2022-05-31 | 333,218 | — | $0 | 333,218 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-05-30 | 2022-05-31 | 111,072 | — | $0 | 466,885 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-05 | 2022-04-05 | 3,335 | $50.68 | $169.0K | 358,109 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-05 | 2022-04-05 | 4,369 | $49.72 | $217.2K | 361,444 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-05 | 2022-04-05 | 2,196 | $51.59 | $113.3K | 355,913 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-05 | 2022-04-05 | 100 | $52.70 | $5.3K | 355,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-03-15 | 2022-03-16 | 4,578 | $41.45 | $189.8K | 371,235 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-03-15 | 2022-03-16 | 5,322 | $42.31 | $225.2K | 365,913 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-03-15 | 2022-03-16 | 100 | $43.18 | $4.3K | 365,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-03-07 | 2022-03-08 | 9,477 | $44.90 | $425.5K | 376,336 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-03-07 | 2022-03-08 | 523 | $45.56 | $23.8K | 375,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-15 | 2022-02-15 | 5,366 | $52.15 | $279.8K | 387,183 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-15 | 2022-02-15 | 3,264 | $51.22 | $167.2K | 392,549 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-15 | 2022-02-15 | 1,370 | $52.74 | $72.3K | 385,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-14 | 2022-02-14 | 4,850 | $50.17 | $243.3K | 395,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-14 | 2022-02-14 | 259 | $50.75 | $13.1K | 400,663 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-14 | 2022-02-14 | 2,079 | $50.16 | $104.3K | 400,922 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-02-10 | 2022-02-14 | 19,245 | — | $0 | 19,245 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-02-10 | 2022-02-14 | 7,595 | — | $0 | 403,001 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-02-10 | 2022-02-14 | 8,203 | — | $0 | 395,406 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-07 | 2022-02-07 | 1,250 | $54.35 | $67.9K | 387,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-07 | 2022-02-07 | 2,290 | $52.77 | $120.8K | 394,913 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-07 | 2022-02-07 | 6,460 | $53.51 | $345.7K | 388,453 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-19 | 1,842 | $63.45 | $116.9K | 398,503 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-19 | 3,434 | $61.71 | $211.9K | 403,769 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-19 | 1,300 | $64.66 | $84.1K | 397,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-18 | 2022-01-19 | 3,424 | $62.37 | $213.6K | 400,345 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 1,106 | $76.90 | $85.1K | 408,459 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 2,397 | $73.18 | $175.4K | 414,806 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 900 | $73.92 | $66.5K | 413,906 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 700 | $75.32 | $52.7K | 413,206 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 3,641 | $76.03 | $276.8K | 409,565 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 100 | $78.91 | $7.9K | 407,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-01-05 | 2022-01-05 | 1,156 | $78.24 | $90.4K | 407,303 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 311 | $76.07 | $23.7K | 419,774 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 520 | $77.24 | $40.2K | 419,254 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 1,524 | $78.21 | $119.2K | 417,730 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 527 | $78.97 | $41.6K | 417,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 3,001 | $71.28 | $213.9K | 424,202 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 1,100 | $72.01 | $79.2K | 423,102 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 1,900 | $73.35 | $139.4K | 421,202 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-15 | 2021-12-16 | 1,117 | $74.50 | $83.2K | 420,085 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-12-06 | 2021-12-07 | 10,000 | $71.33 | $713.3K | 427,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-15 | 2021-11-16 | 986 | $76.67 | $75.6K | 437,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-15 | 2021-11-16 | 2,400 | $75.76 | $181.8K | 438,189 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-15 | 2021-11-16 | 6,614 | $75.02 | $496.2K | 440,589 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-05 | 2021-11-05 | 5,094 | $82.98 | $422.7K | 449,603 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-05 | 2021-11-05 | 2,400 | $83.79 | $201.1K | 447,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-11-05 | 2021-11-05 | 2,506 | $82.09 | $205.7K | 454,697 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-10-01 | 2021-10-04 | 616 | $67.37 | $41.5K | 457,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-10-01 | 2021-10-04 | 4,820 | $66.77 | $321.8K | 457,819 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-10-01 | 2021-10-04 | 2,664 | $65.77 | $175.2K | 462,639 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-10-01 | 2021-10-04 | 1,900 | $64.71 | $122.9K | 465,303 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-09-01 | 2021-09-02 | 3,759 | $68.01 | $255.6K | 467,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-09-01 | 2021-09-02 | 6,241 | $67.23 | $419.6K | 470,962 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-03 | 3,784 | $49.94 | $189.0K | 483,419 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-03 | 4,812 | $51.35 | $247.1K | 478,607 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-03 | 304 | $53.47 | $16.3K | 477,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-03 | 1,100 | $52.59 | $57.8K | 477,507 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-07 | 2021-07-08 | 664 | $46.08 | $30.6K | 501,290 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-07 | 2021-07-08 | 1,050 | $47.28 | $49.6K | 500,240 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-07 | 2021-07-08 | 858 | $47.76 | $41.0K | 499,382 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 2,796 | $46.78 | $130.8K | 502,777 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 769 | $47.17 | $36.3K | 502,008 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 54 | $48.83 | $2.6K | 501,954 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 100 | $48.96 | $4.9K | 487,203 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 11,764 | $46.85 | $551.1K | 487,618 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-06 | 2021-07-08 | 315 | $47.28 | $14.9K | 487,303 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-02 | 2021-07-06 | 200 | $50.86 | $10.2K | 505,573 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-02 | 2021-07-06 | 3,823 | $49.18 | $188.0K | 511,750 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-02 | 2021-07-06 | 5,977 | $49.80 | $297.7K | 505,773 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-02 | 1,272 | $54.61 | $69.5K | 515,573 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-02 | 8,728 | $53.97 | $471.1K | 516,845 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 5,804 | $60.07 | $348.6K | 525,573 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 1,004 | $59.43 | $59.7K | 531,377 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 1,992 | $58.08 | $115.7K | 532,381 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 1,200 | $57.08 | $68.5K | 534,373 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-06 | 2021-04-06 | 165 | $43.26 | $7.1K | 541,063 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 22,714 | $43.41 | $986.0K | 541,228 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 33 | $45.06 | $1.5K | 535,573 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 58 | $44.21 | $2.6K | 535,606 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 5,399 | $43.37 | $234.2K | 535,664 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-03-01 | 2021-03-03 | 10,000 | $41.69 | $416.9K | 563,942 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2021-02-11 | 2021-02-16 | 26,250 | — | $0 | 26,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2021-02-11 | 2021-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2021-02-11 | 2021-02-16 | 5,000 | — | $0 | 573,942 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2021-02-11 | 2021-02-16 | 8,750 | — | $0 | 568,942 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-02-01 | 2021-02-03 | 8,379 | $37.38 | $313.2K | 561,813 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-02-01 | 2021-02-03 | 1,621 | $38.04 | $61.7K | 560,192 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 1,914 | $51.47 | $98.5K | 575,859 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 3,659 | $52.55 | $192.3K | 572,200 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 2,008 | $53.08 | $106.6K | 570,192 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 2,419 | $50.41 | $121.9K | 577,773 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2021-02-03 | 6,597 | $55.50 | $366.1K | 8,773 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2021-02-03 | 3,103 | $54.77 | $170.0K | 15,370 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2021-02-03 | 5,700 | $56.56 | $322.4K | 3,073 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2021-02-03 | 3,073 | $57.22 | $175.8K | 0 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2020-12-28 | 3,103 | — | $0 | 15,370 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2020-12-28 | 6,597 | — | $0 | 8,773 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2020-12-28 | 5,700 | — | $0 | 3,073 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-24 | 2020-12-28 | 3,073 | — | $0 | 0 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-08 | 2020-12-08 | 1,118 | $57.93 | $64.8K | 580,192 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-08 | 2020-12-08 | 13,044 | $57.54 | $750.6K | 581,310 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-08 | 2020-12-08 | 2,226 | $56.08 | $124.8K | 594,354 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-08 | 2020-12-08 | 4,800 | $55.37 | $265.8K | 596,580 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-08 | 2020-12-08 | 1,385 | $54.19 | $75.1K | 601,380 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 123 | $50.84 | $6.3K | 609,334 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 1,006 | $52.53 | $52.8K | 608,328 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 5,158 | $53.71 | $277.0K | 603,170 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 405 | $54.39 | $22.0K | 602,765 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-04 | 2020-12-08 | 3,460 | $50.76 | $175.6K | 613,471 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-04 | 2020-12-08 | 4,014 | $51.17 | $205.4K | 609,457 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 3,203 | $51.65 | $165.4K | 619,231 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 3,468 | $50.86 | $176.4K | 622,434 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 1,029 | $49.82 | $51.3K | 625,902 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 2,300 | $52.71 | $121.2K | 616,931 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-11-23 | 2020-11-25 | 1,165 | $47.30 | $55.1K | 626,931 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-11-23 | 2020-11-25 | 8,835 | $46.44 | $410.3K | 628,096 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 13,394 | — | $0 | 13,394 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy deriv | 2020-11-19 | 2020-11-25 | 1,574 | — | $0 | 1,574 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | P Buy | 2020-11-19 | 2020-11-25 | 8,865 | — | $0 | 23,354 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 52,825 | — | $0 | 52,825 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award deriv | 2020-11-05 | 2020-11-09 | 35,663 | — | $0 | 35,663 | SEC↗ |
| OCUP Ocuphire Pharma, Inc. | A Award | 2020-11-05 | 2020-11-09 | 14,489 | — | $0 | 14,489 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2020-04-07 | 2020-04-09 | 73,478 | — | $0 | 489,143 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2014-01-23 | 2014-01-24 | 10,000 | — | $0 | 35,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-10-31 | 9,000 | — | $0 | 25,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-10-17 | 2012-10-19 | 400,000 | — | $0 | 400,000 | SEC↗ |